Multidisciplinary Insights Into the Assessment, Diagnosis, and Management of Hypogonadism
It is the policy of the Annenberg Center to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All faculty and planners participating in sponsored programs are expected to identify and reference off- label product use and disclose any significant relationships with those supporting the activity or any others whose products or services are discussed. The faculty for this activity have disclosed that there will be discussion about the use of products for non–FDA-approved indications.
Martin M. Miner, MD, receives research support from Auxilium Pharmaceuticals, Inc., and Indevus Pharmaceuticals, Inc., and is a consultant for Sanofi-Aventis.
Ajay Nehra, MD, is a consultant for American Medical Systems;
Bayer Pharmaceuticals Corporation; Pharmaceuticals, Inc.; and Pfizer Inc.
Richard Sadovsky, MD, is a consultant for Eli Lilly and Company and Pfizer Inc and serves on the speakers bureau of Pfizer Inc.
In accordance with the Accreditation Council for Continuing Medical Education standards, parallel documents from other accrediting bodies, and Annenberg Center policy, the following disclosures have been made:
Glenn R. Cunningham, MD, has received speakers bureau honoraria from Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc; and Solvay S.A.; consultant honoraria from Indevus Pharmaceuticals, Inc., and Solvay S.A.; advisor honoraria from Columbia Laboratories, Inc., and Indevus Pharmaceuticals, Inc.; and investigator grants from Ardana Bioscience; Ascend Therapeutics, Inc.; Columbia Laboratories, Inc.; Sanofi-Aventis; and Solvay S.A.
Robert S. Tan, MD, has received research grants from Solvay Pharmaceuticals and serves on the speakers bureau of Lilly ICOS LLC.
The ideas and opinions presented in this education activity are those of the faculty and do not necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational activities, we encourage the practitioners to use their own judgment in treating and addressing the needs of each individual patient, taking into account that patient’s unique clinical situation. The Annenberg Center disclaims all liability and cannot be held responsible for any problems that may arise from
participating in this activity recommendations presented.
Ridwan Shabsigh, MD, has received speakers bureau honoraria from American Medical Systems; Auxilium Pharmaceuticals, Inc.; Bayer Pharmaceuticals Corp.; Eli Lilly and Company; and Schering-Plough Corporation; and consultant honoraria from American Medical Systems; Bayer Pharmaceuticals Corp.; Boehringer Ingelheim; Eli Lilly and Company; Indevus Pharmaceuticals, Inc.; Johnson & Johnson; Lilly; Pfizer Inc; and Schering-Plough Corporation.
This activity is supported by an independent educational grant provided by Indevus Pharmaceuticals, Inc.
This activity is an enduring material and consists of a printed monograph. Successful completion is achieved by reading the material, reflecting on its implications in your practice, and completing the assessment component.
The estimated time to complete this activity is 1.5 hours.
André T. Guay, MD, receives research support from Auxilium Pharmaceuticals, Inc; Pfizer Inc; Solvay S.A.; VIVUS, Inc.; and Zestra Laboratories, Inc. He is a consultant for and serves on the speakers bureaus of Auxilium Pharmaceuticals, Inc.; Cellergy Pharmaceuticals, Inc.; GlaxoSmithKline; Lilly ICOS LLC; Procter & Gamble; and Solvay S.A.
This activity was originally released September 30, 2008, and is eligible for credit through September 30, 2009.
This piece is based on presentations from faculty members and was written by a medical writer. Faculty have final editorial control for the piece.